Dr. Canal has discovered a promising treatment approach for Fragile X syndrome: new compounds which specifically and potently boost serotonin in the brain. The target is the brain's serotonin 1A receptor.
Learn more about this FRAXA funded research grant: www.fraxa.org/...
FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.
Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.
To learn more about FRAXA's Fragile X syndrome research, to get involved with Fragile X awareness and events or to donate to FRAXA research, visit www.fraxa.org
Let's Connect
Facebook: / fraxaresearch
Instagram: / fraxaresearch
LinkedIn: / fraxa-research-foundation
Twitter: / fraxaresearch
Website: www.fraxa.org
Негізгі бет Targeting Serotonin 1A Receptors in Fragile X
No video
Пікірлер: 1